Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
GCMCDTI: Graph convolutional autoencoder framework for predicting drug-target interactions based on matrix completion
Jing Li1, Chen Zhang1, Zhengwei Li1
1School of Computer Science and Technology, China University of Mining and Technology, Xuzhou, Jiangsu 221116, P. R. China.
Abstract:
Identification of potential drug-target interactions (DTIs) plays a pivotal role in the development of drug and target discovery in the public healthcare sector. However, biological experiments for predicting interactions between drugs and targets are still expensive, complicated, and time-consuming. Thus, computational methods are widely applied for aiding drug-target interaction prediction. In this paper, we propose a novel model, named GCMCDTI, for DTIs prediction which adopts a graph convolutional network based on matrix completion. We regard the association prediction between drugs and targets as link prediction and treat the process as matrix completion, and then a graph convolutional auto-encoder framework is employed to construct the drug and target embeddings. Then, a bilinear decoder is applied to reconstruct the DTI matrix. We conduct our experiments on four benchmark datasets consisting of enzymes, G protein-coupled receptors (GPCRs), ion channels, and nuclear receptors. The five-fold cross-validation results achieve the high average AUC values of 95.78%, 95.31%, 93.90%, and 91.77%, respectively. To further evaluate our method, we compare our proposed method with other state-of-the-art approaches. The comparison results illustrate that our proposed method obtains improvement in performance on DTI prediction. The proposed method will be a good choice in the field of DTI prediction.
More Related Videos
Related Concept Videos
Predicting Reaction Outcomes
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Quantitative Aspects of Drug-Receptor Interaction
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Protein-protein Interfaces
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

